That theory triumphed and led to the 2017 approval of ocrelizumab, the first in a new class of therapies for MS. “A few decades ago, young scientists were advised to pick another disease to study,” ...

4 Department of Epidemiology, Harvard School of Public Health, Boston, USA 5 Department of Nutrition, Harvard School of Public Health 6 Department of Health and Social Behavior, Harvard School of ...

Hospitals could be short-changing patients if they lean too heavily on nurse staffing agencies or overtime hours, a new study says. Patients are much more likely to develop bedsores at short ...

The resulting shortages could reverberate through emergency departments and hospitals, leading to the inability to discharge patients and tying up nurses and other staff." Outside the study ...